Dahlia Sataloff, MD, FACS, is a Professor of Clinical Surgery and the Chair of Surgery at Pennsylvania Hospital. To learn more about her work, career and motivations, read our interview with Dr. Sataloff.

In 2017, the FDA approved the first cellular therapy for cancer, a living drug called Kymriah, developed at Penn by Dr. Carl June. Learn more about the significance of this new method of therapy and other revolutionary research being conducted at Penn.

Abramson Cancer Center's Pancreatic Research Center, led by Dr. Ben Stranger, is revolutionizing the way this disease is treated. Learn more about pancreatic cancer clinical trials at Penn and why there is now hope for all stages.

Patricia Gambino, MSN, RN is a nurse navigator for GI oncology patients at Abramson Cancer Center. To learn more about her role as a nurse navigator, check out our interview with Patricia.

It’s the leading cause of death in women and on the rise among women who have never smoked. But there’s still plenty that women can do to get ahead of lung cancer.